Group One Trading
NERV icon

Group One Trading’s Minerva Neurosciences NERV Stock Holding History

Group One Trading’s Portfolio NERV Stock Details NERV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-54,900
Closed -$87.3K – 7687
2022
Q4 		$87.3K Sell
54,900
-400
-0.7% -$1.73K ﹤0.01% 4549
2022
Q3 		$510K Hold
55,300
– – ﹤0.01% 3208
2022
Q2 		$183K Buy
55,300
+48,425
+704% +$198K ﹤0.01% 4392
2022
Q1 		$46K Buy
6,875
+4,100
+148% +$25.2K ﹤0.01% 6159
2021
Q4 		$18K Sell
2,775
-3,738
-57% -$35.2K ﹤0.01% 7033
2021
Q3 		$91K Buy
6,513
+2,275
+54% +$34.2K ﹤0.01% 5998
2021
Q2 		$79K Buy
4,238
+3,600
+564% +$77.5K ﹤0.01% 6183
2021
Q1 		$15K Sell
638
-2,837
-82% -$70.9K ﹤0.01% 6885
2020
Q4 		$65K Sell
3,475
-19,838
-85% -$500K ﹤0.01% 4838
2020
Q3 		$593K Sell
23,313
-24,262
-51% -$656K ﹤0.01% 2692
2020
Q2 		$1.37M Buy
47,575
+37,212
+359% +$2.18M 0.01% 1761
2020
Q1 		$499K Buy
+10,363
New +$625K ﹤0.01% 2053
2019
Q3 		– Sell
-25
Closed -$1K – 5407
2019
Q2 		$1K Buy
+25
New +$1.25K ﹤0.01% 4821
2017
Q3 		– Sell
-125
Closed -$9K – 5041
2017
Q2 		$9K Buy
+125
New +$8.09K ﹤0.01% 4244

Other funds holding NERV

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return

Group One Trading's NERV Position: Q1 2023 in Review

Group One Trading sold out of Minerva Neurosciences (NERV) in Q1 2023, closing a stake of 5,785 shares — an estimated $9.2K sold.

Group One Trading first reported a position in NERV in Q3 2016 and held it in 17 quarters. The position peaked at $745K in Q1 2020. 17 funds tracked by Wall St. Rank hold NERV as of Q1 2023.

  • Group One Trading reported no remaining Minerva Neurosciences position as of Q1 2023 after selling out during the quarter.
  • Group One Trading sold 5,785 Minerva Neurosciences shares in Q1 2023, an estimated $9.2K.
  • Group One Trading first reported a position in Minerva Neurosciences in Q3 2016 and held it in 17 quarters.
  • Group One Trading's Minerva Neurosciences position peaked at $745K in Q1 2020.
  • 17 funds tracked by Wall St. Rank held Minerva Neurosciences as of Q1 2023.

Based on Group One Trading's 13F filing for Q1 2023, filed 12 May 2023.